Clinical trial
Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma…
NCT00394914 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00394914 |
|---|---|
| Title | Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) |
| Official title | A Placebo-Controlled Study of the Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma, Common Cold, Picornavirus Infection, Rhinovirus |
| Intervention type | Drug |
| Interventions | Pleconaril, Placebo to Pleconaril |
| Enrollment | 311 |
| Start date | Aug 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Nov 2, 2006 |
| Last update posted | Jul 16, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: